Auxilium Pharmaceuticals Inc. (AUXL)

AUXL (NASDAQ:Drugs)
$15.13
pos +0.03
+0.20%
Today's Range: 14.94 - 15.28 | AUXL Avg Daily Volume: 787,700
Last Update: 05/21/13 - 4:00 PM EDT
Volume: 695,499
YTD Performance: -19.04%
Open: $15.15
Previous Close: $15.10
52 Week Range: $13.87 - $29.37
Oustanding Shares: 49,306,028
Market Cap: 740,083,480
6-Month Chart
TheStreet Ratings Grade for AUXL
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 7 5 6 6
Moderate Buy 1 1 1 1
Hold 2 3 3 3
Moderate Sell 0 0 0 0
Strong Sell 1 2 2 2
Mean Rec. 1.82 2.30 2.19 2.19
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: 9.32
Price Earnings Comparisons:
AUXL Sector Avg. S&P 500
9.32 9.30 17.70
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
-12.53% -17.62% -55.21%
GROWTH 12 Mo 3 Yr CAGR
Revenue 49.50 1.41 0.34
Net Income 0.00 -2.61 0.00
EPS 0.00 -2.44 0.00
Earnings for AUXL:
EBITDA 0.10B
Revenue 0.40B
Average Earnings Estimates
Qtr (06/13) Qtr (09/13) FY (12/13) FY (12/14)
Average Estimate $-0.07 $0.00 $-0.02 $0.37
Number of Analysts 3 2 5 5
High Estimate $0.12 $0.07 $0.41 $1.38
Low Estimate $-0.30 $-0.08 $-0.51 $-0.95
Prior Year $0.16 $-0.21 $1.74 $-0.02
Growth Rate (Year over Year) -141.67% 97.62% -101.03% 2,155.56%
Update Chart
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
StockSignaling
StockSignaling: Healthcare Sector: Upgrades: $SGMO $ARNA $DCTH $AVEO $SNTA $AUXL $FVE $AMED $WLP $BIOL $CPRX $ENTA $ROSG $PCRX $MASI http://t.co/Vtx6dLy0Nw
1 hour ago from Stock Signaling
fredmartin121
fredmartin121: @BrandonUK07 heavy call buying $auxl
3 hours ago from web
TradeStudent101
TradeStudent101: Heavy call buying in $AUXL $SNE $CTSH
8 hours ago from web
C_S_1313
C_S_1313: $AUXL huge trade went
14 hours ago from web
micenter
micenter: Auxillium Pharmaceuticals $AUXL Showing Bearish Technicals With Resistance At $15.29 ( http://t.co/7QKGwb3ju9 )
15 hours ago from Marketintelligencecenter.com
BV_Healthcare
BV_Healthcare: $AUXL Auxilium Pharmaceuticals Inc Files 8-K : Regulation FD, Financial Statements.. http://t.co/D3hd6MsTe8
20 hours ago from BoardVote.com
optiongestion
optiongestion: "@StockSignaling: Healthcare Sector: Upgrades: $SGMO $ARNA $DCTH $AVEO $SNTA $AUXL $FVE $AMED $WLP $BIOL $CPRX $ENTA $ROSG $PCRX $MASI h
1 day ago from Twitter for Android
StockSignaling
StockSignaling: Healthcare Sector: Upgrades: $SGMO $ARNA $DCTH $AVEO $SNTA $AUXL $FVE $AMED $WLP $BIOL $CPRX $ENTA $ROSG $PCRX $MASI http://t.co/Vtx6dLy0Nw
1 day ago from Stock Signaling
BrandonUK07
BrandonUK07: @fredmartin121 $auxl stayed w/in trendlines drawn on chart yesterday. Still looking for a break of the longer downward trend-line soon.
1 day ago from web
lcdnews
lcdnews: Auxilium Pharmaceuticals sets launch of $225M leveraged loan for acquisition of Actient Holdings $ http://t.co/pRhQ1l26Wj $AUXL #biopharma
2 days ago from HootSuite

bullishAuxilium upgraded at Morgan Stanley

May 3, 2013 | 8:26 AM EDT

AUXL was upgraded from Underweight to Equal-weight, Morgan Stanley said. Risk/reward is more attractive, following a 50% decline since July. $14 price target. 

Stocks Under $5: Discount Drug Name

By

David Peltier

 | Nov 29, 2012 | 6:00 AM EST

Portfolio Mgr. David Peltier analyzes a volatile, low-dollar drug stock.

bearishAuxilium Pharma numbers lowered at Jefferies

Nov 8, 2012 | 8:22 AM EST

Shares of AUXL now seen reaching $29, Jefferies said. Estimates also lowered on Testim miss. Buy rating.

Stocks Under $10: Stealth Drug Play

By

David Peltier

 | Aug 29, 2012 | 6:00 AM EDT

Portfolio David Peltier finds a pharma name that's quietly growing faster than its peers.

bullishAuxilium Pharma numbers raised at Jefferies

Aug 1, 2012 | 8:43 AM EDT

Shares of AUXL now seen reaching $32, Jefferies said. Estimates also raised on first quarter results. Buy rating.

bullishAuxilium Pharmaceutical numbers raised at UBS

Aug 1, 2012 | 8:38 AM EDT

Shares of AUXL now seen reaching $32, UBS said. Estimates also increased as Testim sales ramp should drive upside. Buy rating.

bearishAuxilium downgraded at Leerink

Aug 1, 2012 | 8:03 AM EDT

AUXL was downgraded to Market Perform, Leerink Swann said. Company lacks near-term catalysts. $25 price target. 

bullishAuxilium Pharma target raised at Jefferies

Jun 5, 2012 | 8:16 AM EDT

Shares of AUXL now seen reaching $30, Jefferies said. Good buying opportunity on positive Peyronie's data. Buy rating.

Stocks Under $10: Healthcare Name on Sale

By

David Peltier

 | May 17, 2012 | 7:30 AM EDT

Portfolio Manager David Peltier uncovers a drugmaker that's pulled back to an attractive level.

Columnist Conversation / Market Updates

NetApp (NTAP): Storing Up Disappointment
By

Chris Laudani

 | May 21, 2013 | 5:33 PM EDT
Co misses on revenues. Revenue rose (if you can call it that) 0.8% to $1.7 bin. (I was looking for 1.7% y/y rev growth.)...

Making a late move on NTAP
By

Robert Lang

 | May 21, 2013 | 3:46 PM EDT
We added a call spread for NTAP here, not as pricey as the move implies, the chart not looking too bad. I like this for...
See more »

Our Tweets

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.